Overview

This course provides the active, intermediate-to-advanced clinician with a comprehensive review of the science of HIV and key infections including Hepatitis, RSV and COVID, as well as an update on the application of appropriate therapies. For ambitious new clinicians who want a challenge, we still offer our New Clinicians Track (NCT). This track provides five additional lectures that cover antiretroviral therapy (ART) 101, basic HIV pharmacology, management of ART resistance, IRIS, and opportunistic infections. All course lecturers are leading clinicians and teachers who are dedicated to teaching in their areas of expertise.

Downstream effects of acute and Long COVID continue to amplify existing health disparities and contribute to the vulnerability of all of our patients, making the need for up-to-date information about HIV/AIDS, HCV,HBV, add RSV, COVID and other key infections essential for providing high quality care. Current treatment options for acute COVID and understanding the science and management of Long COVID will be addressed.

All lectures will be cased-based with at least 2-4 ARS questions per session. Question and answer time as well as faculty panels are weaved into each conference day. The panels are designed with ARS questions so that you can privately test your individual knowledge against the experts throughout the conference. Questions that arise in the Chat will be answered throughout each conference day by our enthusiastic faculty.

TARGET AUDIENCE
This course is designed for practicing internists, family practice physicians, infectious disease specialists, nurse practitioners, physician assistants and pharmacists. For three days, we will focus on the breadth of practical issues in the care of people living with HIV/AIDS, infectious hepatitis, RSV, H5N1, COVID and other key infections.

Onsite and Remote Learning Options:
The course will be offered as a live conference. Registrants have the option to attend in person or to tune in remotely via zoom live stream during programming hours (Pacific Time). Login instructions along with the digital syllabus will be shared with attendees before the meeting. Included in your registration fee is access to the course recordings on demand after the conference and for 30 days after the course. You must tune in to the live conference (in person or remotely) to claim CME.
**Fully Virtual on December 7, 2024 for all attendees**

Objectives

An attendee completing this course will be able to improve skills and strategies to:

• Diagnose, treat, and prevent important conditions in HIV medicine and HIV medicine subspecialties, for improved patient outcomes;
• Apply in practice the latest treatment guidelines and recommendations for the prevention of HIV transmission and the appropriate use of PEP, PrEP, and DoxyPEP;
• Apply new recommendations for initiating and timely switching of antiretroviral combinations, and the use of long acting therapy in appropriate patients;
• Identify the new developments and apply treatment recommendations in HIV related GI, cardiac, psychiatric and dermatologic disease as well as addiction medicine;
• Apply new recommendations for the treatment of HCV, HBV, cirrhosis, MASH and MAFLD.
• Align practice patterns more with current evidence and guidelines for treating STI’s, and HIV.
• Apply in practice the recommendations for the prevention of RSV, H5N1, and COVID transmission and the updated treatment guidelines for RSV, H5N1, and COVID
• Apply new recommendations for appropriate treatment of acute COVID and Long COVID